Authors
Nan Gao, Hanke Zhang, Qirui Gong, Jianwen Wang, Cong Ma, Guangxu Wang, Zishen Xia, Kangwei Wang, Aiwen Gui, Wei Liu, Guohui Liu, Lihong Fan, Yuxiong Weng
Published in
Biomaterials advances. Volume 188. Pages 215016. Jun 13, 2026. Epub Jun 13, 2026.
Abstract
Diabetic wound management is compromised by infection, oxidative stress, and viscous exudates that dilute therapeutic agents. We report a spatially organized bilayer polyurethane scaffold designed to address these barriers. The scaffold integrates: (i) a hydrophilic layer with covalently bound L-arginine and ascorbic acid for degradation-dependent nitric oxide generation and ROS scavenging; (ii) a hydrophobic layer presenting REDV peptides for endothelial recruitment; and (iii) aligned microchannels with engineered wettability gradients enabling directional transport of viscous exudates (up to 90 mPa·s). This architectural segregation prevents therapeutic dilution while promoting regeneration. In diabetic infected wounds, the scaffold achieved 91.7% closure by day 12, significantly outperforming controls (43.8%) and commercial Tegaderm (56.7%). Treatment facilitated bacterial clearance, inflammatory resolution (reduced TNF-α/IL-1β, elevated IL-10), growth factor upregulation, and robust vessel maturation. These findings demonstrate that orchestrating degradation-dependent therapeutic release with directional fluid transport offers a potent translational strategy for chronic wound treatment.
PMID:
42320089
Bibliographic data and abstract were imported from PubMed on 20 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0